Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

10 Feb 2011 16:30

RNS Number : 0489B
Oryx International Growth Fund Ld
10 February 2011
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2010

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2010 to 31 December 2010, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

 

The FTSE All-Share TR Index (£) returned 7.38% over the fourth quarter. Risk assets were in demand after the announcement of further quantitative easing in the United States and on the back of greater economic optimism, particularly on signs of recovery in the US economy. December was a particularly strong month for developed market equities including the UK stock market. Reflecting this increased risk appetite, the FTSE Small Cap TR Index outperformed the broad index, returning 9.05%. Against this backdrop, the Fund's NAV rose by 11.28%, while its share price advanced 20.25% to £2.375. The discount to NAV narrowed sharply from 21.72% at the start of the quarter to 15.41% at the end of December.

 

 

Material Transactions

Since 1 October 2010 the Company has purchased for cancellation the following shares:

 

12 November 2010 a total of 15,000 ordinary shares at a gross price of £2.10 per share.

19 November 2010 a total of 15,000 ordinary shares at a gross price of £2.10 per share.

10 December 2010 a total of 37,860 ordinary shares at a gross price of £2.15 per share.

 

 

Material Events

There were no material events during the quarter ended 31 December 2010.

 

 

Report and Accounts

On 11 November 2010, the Company posted its Interim Report for the six months ended 30 September 2010, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2010

30 June 2010

31 March 2010

31 December 2009

 

 

 

 

 

NAV

£2.81

£2.35

£2.28

£2.26

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5657

 

1.4961

 

1.5169

 

1.4378

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2010

 

%

Chrysalis Group Plc

9.66

Gleeson (M J) Group Plc

6.89

BBA Aviation Plc

6.71

CVS Group Plc

5.78

RPC Group Plc

5.25

Idox Plc

4.84

Quarto Group Inc

4.79

Catalyst Media Group Plc

4.46

Orthoproducts Ltd

4.41

Bavaria Industriekapital AG

4.30

Journey Group Plc

4.03

IS Pharma Plc

3.90

Phoenix Group Holdings

3.18

Augean

3.01

Innovation Group Plc

2.85

Focus Solutions Group Plc

2.76

Vislink Plc

2.63

Nastor Inv Ltd Zero Dividend Preference Shares

2.52

Assetco Plc

2.30

RPC Group Plc nrp rts 21/01/2011

1.93

% of total portfolio

86.20

 

The financial information for the quarter ended 31 December 2010 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAPPUPGGQU
Date   Source Headline
12th Nov 20204:34 pmRNSHolding(s) in Company
5th Nov 20204:35 pmRNSTR-1
26th Oct 20204:50 pmRNSHoldings in Company
19th Oct 20209:12 amRNSHolding(s) in Company
14th Oct 20204:35 pmRNSNet Asset Value(s)
14th Oct 20208:00 amRNSHolding(s) in Company
1st Oct 202012:29 pmRNSTotal Voting Rights
25th Sep 202012:49 pmRNSNotification of Major Shareholdings
23rd Sep 202011:09 amRNSNet Asset Value(s)
9th Sep 20202:03 pmRNSTransaction in Own Shares
8th Sep 20203:06 pmRNSHolding(s) in Company
1st Sep 20203:48 pmRNSHolding(s) in Company
28th Aug 202011:25 amRNSResult of AGM
24th Aug 20203:11 pmRNSNet Asset Value(s)
7th Aug 20208:56 amRNSHolding(s) in Company
4th Aug 20201:06 pmRNSHolding(s) in Company
31st Jul 20202:58 pmRNSNotice of AGM
23rd Jul 20204:27 pmRNSHolding(s) in Company
23rd Jul 20202:55 pmRNSAnnual Financial Report
22nd Jul 202010:23 amRNSNet Asset Value(s)
20th Jul 20202:08 pmRNSHolding(s) in Company
17th Jul 202012:19 pmRNSHolding(s) in Company
2nd Jul 202011:07 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSHolding(s) in Company
22nd Jun 20203:54 pmRNSNet Asset Value(s)
29th May 20208:31 amRNSHolding(s) in Company
26th May 202012:39 pmRNSNet Asset Value(s)
22nd May 202011:10 amRNSHolding(s) in Company
4th May 20201:46 pmRNSNet Asset Value(s)
1st May 20203:19 pmRNSHolding(s) in Company
20th Apr 20201:24 pmRNSHolding(s) in Company
20th Apr 20201:23 pmRNSHolding(s) in Company
14th Apr 20203:06 pmRNSHolding(s) in Company
6th Apr 20208:34 amRNSHolding(s) in Company
18th Mar 20204:22 pmRNSNet Asset Value(s)
10th Mar 20202:14 pmRNSHolding(s) in Company
6th Mar 20203:57 pmRNSHolding(s) in Company
26th Feb 20203:03 pmRNSHolding(s) in Company
24th Feb 20204:31 pmRNSNet Asset Value(s)
18th Feb 20203:19 pmRNSHoldings in Company
11th Feb 202012:31 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSNet Asset Value(s)
17th Jan 20204:05 pmRNSHolding(s) in Company
17th Jan 20209:22 amRNSHolding(s) in Company
10th Jan 20205:39 pmRNSHolding(s) in Company
8th Jan 20201:35 pmRNSHolding(s) in Company
8th Jan 20201:34 pmRNSHolding(s) in Company
8th Jan 202012:13 pmRNSHolding(s) in Company
20th Dec 20195:01 pmRNSNet Asset Value(s)
18th Dec 20192:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.